Skip to main content
Caplight Logo









Genisphere LLC

Genisphere LLC

Private
Hatfield, PennsylvaniaHealthcare & Life Scienceshttps://wawamenus.com/wawa-store-locator/

Last Round

VC Round

Nov 1, 2017

Company Overview

Genisphere LLC is a biotechnology company that develops a DNA-based nanotechnology platform called 3DNA for targeted drug delivery and clinical diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

targeted drug deliverynanotechnology3DNAmolecular diagnosticsdrug delivery platformnanocarrierssignal amplificationbiotech reagentsRNA amplificationprecision medicinedrug developmentnanomedicinebiotech licensingnucleic acid detectionlab reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genisphere LLC Comparables

Compare Genisphere LLC with similar companies based on industry and business-model similarity.

Genisphere LLC comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Code Biotherapeutics
86%
Phoreus Biotechnology, Inc.
83%
DoriNano
81%

Genisphere LLC Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 1, 2017
VC RoundOct 1, 2015
VC RoundSep 16, 2014

Key People

Founding team and executive leadership

James Kadushin

Co-Founder (Retired), VP Operations COO

Founding Team

Jim Kadushin

VP Operations Chief Operating Officer

Executive Team

Genisphere LLC Investors

Notable investors and investment history

Genisphere LLC investors
InvestorRounds
Corporate Fuel AdvisorsVC Round
Lankenau Institute for Medical ResearchVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2017

    Raised $7M in a VC Round.

Genisphere LLC Filings

Explore SEC and related filing metadata, where available.

Genisphere LLC filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genisphere LLC's valuation, stock price, and market status.

Is Genisphere LLC a public or private company?

Genisphere LLC is a private company.

What is the current stock price of Genisphere LLC?

Genisphere LLC is a private company, so its shares have no public market price. Caplight tracks Genisphere LLC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Genisphere LLC worth (valuation)?

Valuation information for Genisphere LLC is not publicly available.

Can I buy Genisphere LLC stock?

Genisphere LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Genisphere LLC's last funding round?

Genisphere LLC's most recent funding round was VC Round on November 1, 2017.

Who are the main investors in Genisphere LLC?

Key investors in Genisphere LLC include Corporate Fuel Advisors, Lankenau Institute for Medical Research.

Will Genisphere LLC IPO soon?

No public IPO plans have been announced for Genisphere LLC.

How can I track Genisphere LLC secondary market activity?

Caplight tracks bids, offers, and trades in Genisphere LLC's shares on secondary markets.

Firmographic Details

HeadquartersHatfield, Pennsylvania
Employee Range7
Year Founded1997
Last FundingNov 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?